🔎 Trials Near Me

Home › Delirium › NCT03901924

Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

Recruiting

A Phase III Randomized Trial Comparing the Effects of Volume Support and Assist Control Mode Ventilation on Ventilator-Free Days and Diaphragmatic Atrophy

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

subjects \> 18 years of age that have been intubated and mechanically ventilated for \< 36 hours at the time of screening will be eligible for enrollment

Exclusion Criteria:

1. pregnancy
2. cardiopulmonary arrest
3. history of diaphragmatic paralysis or neuromuscular disease
4. chronic obstructive pulmonary disease (COPD) or asthma exacerbation with evidence of auto-PEEPing requiring intubation
5. neuromuscular blockade
6. expectation to be liberated from ventilator in \< 24 hours
7. history of mechanical ventilation in the last 6 months
8. presence of tracheostomy
9. high cervical spine injury

About the study

The objective of the study is to determine how controlled mode ventilation and support mode ventilation impact ventilator-free days and diaphragmatic atrophy.

What is being tested

Sponsor: University of Chicago · Participants: 468 · Started: Mar 4, 2019

Contact the study team

Official record on ClinicalTrials.gov — NCT03901924

Locations in the U.S.

IllinoisThe University of Chicago Medical Center, Chicago
IowaUniversity of Iowa, Iowa City (Not yet recruiting)

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.